<SEC-DOCUMENT>0001193125-21-225852.txt : 20210727
<SEC-HEADER>0001193125-21-225852.hdr.sgml : 20210727
<ACCEPTANCE-DATETIME>20210727165741
ACCESSION NUMBER:		0001193125-21-225852
CONFORMED SUBMISSION TYPE:	424B3
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20210727
DATE AS OF CHANGE:		20210727

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			IRIDEX CORP
		CENTRAL INDEX KEY:			0001006045
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		IRS NUMBER:				770210467
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0102

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-257807
		FILM NUMBER:		211118390

	BUSINESS ADDRESS:	
		STREET 1:		1212 TERRA BELLA AVE
		CITY:			MOUNTAIN VIEW
		STATE:			CA
		ZIP:			94043
		BUSINESS PHONE:		6509404700

	MAIL ADDRESS:	
		STREET 1:		1212 TERRA BELLA AVENUE
		CITY:			MOUNTAIN VIEW
		STATE:			CA
		ZIP:			94043
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B3
<SEQUENCE>1
<FILENAME>d202221d424b3.htm
<DESCRIPTION>424B3
<TEXT>
<HTML><HEAD>
<TITLE>424B3</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Filled Pursuant to Rule 424(b)(3)<BR>Registration No. 333-257807 </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PROSPECTUS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g202221g03a20.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>IRIDEX CORPORATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>1,618,122 Shares of Common Stock </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The selling
stockholder identified in this prospectus or their transferees or other <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">successors-in-interest</FONT></FONT> identified in a prospectus supplement (the &#147;Selling
Stockholders&#148;) may sell or otherwise dispose of up to 1,618,122 shares of our common stock, par value $0.01 per share. We are not offering any shares of common stock under this prospectus and will not receive any proceeds from the sale or other
disposition of the shares covered hereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Selling Stockholders (which term includes their respective donees, pledgees, transferees or
other <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">successors-in-interest)</FONT></FONT> may, from time to time, sell, transfer or otherwise dispose of the shares or interests therein on any stock exchange, market or trading
facility on which the shares are traded or in private transactions at fixed prices, at market prices prevailing at the time of sale, at prices related to the prevailing market price, at varying prices determined at the time of sale, or at negotiated
prices. The Selling Stockholders will bear all fees, discounts, concessions or commissions of broker-dealers or agents in connection with the offering of the shares by the Selling Stockholders. See &#147;<A HREF="#toc202221_8">Plan of
Distribution</A>&#148; beginning on page 13 of this prospectus for more information about how the Selling Stockholders may sell their shares of common stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our common stock is traded on The Nasdaq Global Market under the symbol &#147;IRIX&#148;. On July&nbsp;8, 2021, the last reported sale price
of our common stock on The Nasdaq Global Market was $6.85 per share. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:12pt; font-family:Times New Roman"><B>Investing in
our common stock involves a high degree of risk. You should carefully read and consider the risk factors described in, and incorporated by reference under, &#147;<A HREF="#cov202221_1">Risk Factors</A>&#148; beginning on page 5 of this prospectus
and or as updated by any subsequent filing with the Securities and Exchange Commission before investing in any securities. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Neither
the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense. </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The date of this prospectus is July&nbsp;27, 2021. </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="97%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc202221_1">ABOUT THIS PROSPECTUS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc202221_2">CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc202221_3">PROSPECTUS SUMMARY</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc202221_4">RISK FACTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc202221_5">USE OF PROCEEDS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc202221_6">DESCRIPTION OF CAPITAL STOCK</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc202221_7">SELLING STOCKHOLDERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc202221_8">PLAN OF DISTRIBUTION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc202221_9">LEGAL MATTERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc202221_10">EXPERTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc202221_11">WHERE YOU CAN FIND MORE INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc202221_12">INFORMATION INCORPORATED BY REFERENCE</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-i- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc202221_1"></A>ABOUT THIS PROSPECTUS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus is part of a Registration Statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> (the &#147;Registration
Statement&#148;) that we filed with the United States Securities and Exchange Commission (the &#147;SEC&#148;). Under this Registration Statement, the Selling Stockholders may sell, at any time and from time to time, in one or more offerings, up to
1,618,122 shares of common stock. When the Selling Stockholders elect to make an offer of any common stock described in this prospectus, pursuant to this Registration Statement, a prospectus supplement, if required, may be distributed that will
contain specific information about the terms of that offering. Any required prospectus supplement may also add, update or change information contained in this prospectus. It is important for you to read and consider all information contained in this
prospectus, including the documents incorporated by reference therein, in making your investment decision. You should also read and consider the information in the documents to which we have referred you under the captions &#147;Where You Can Find
Additional Information&#148; and &#147;Information Incorporated by Reference&#148; in this prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have not authorized any dealer,
salesman or other person to give any information or to make any representation other than those contained or incorporated by reference in this prospectus. You should only rely on the information contained or incorporated by reference in this
prospectus and any prospectus supplement. No person has been authorized to give any information or make any representations other than those contained or incorporated by reference in this prospectus or any accompanying prospectus supplement in
connection with the offering described herein and therein, and, if given or made, such information or representations must not be relied upon as having been authorized by us or the Selling Stockholders. Persons who come into possession of this
prospectus in jurisdictions outside the United States are required to inform themselves about, and to observe, any restrictions as to the offering and the distribution of this prospectus applicable to those jurisdictions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus incorporates by reference market data, industry statistics and other data that have been obtained from, or compiled from,
information made available by third parties. We have not independently verified their data. You should read the entire prospectus and any prospectus supplement, as well as the documents incorporated by reference into this prospectus or any
prospectus supplement, before making an investment decision. Neither the delivery of this prospectus or any prospectus supplement nor any sale made hereunder shall under any circumstances imply that the information contained or incorporated by
reference herein or in any prospectus supplement is correct as of any date subsequent to the date hereof or of such prospectus supplement, as applicable. You should assume that the information appearing in this prospectus, any prospectus supplement
or any document incorporated by reference is accurate only as of the date of the applicable documents, regardless of the time of delivery of this prospectus or any sale of securities. Our business, financial condition, results of operations and
prospects may have changed since that date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus may be supplemented from time to time by one or more prospectus supplements.
Any such prospectus supplements may include additional or different information, such as additional or different risk factors or other special considerations applicable to us or our business, financial condition or results of operations. If there is
any inconsistency between the information in this prospectus and any prospectus supplement, you should rely on the information contained in the prospectus supplement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus is neither an offer to sell nor a solicitation of an offer to buy any securities other than those registered by this
prospectus, nor it is an offer to sell or a solicitation of an offer to buy securities where an offer or solicitation would be unlawful. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless the context requires otherwise, references in this prospectus to &#147;IRIDEX,&#148; &#147;the company,&#148; &#147;we,&#148;
&#147;us&#148; and &#147;our&#148; refer to IRIDEX Corporation, a Delaware corporation, and our consolidated subsidiaries. This prospectus, including the documents incorporated herein by reference, contains references to a number of trademarks that
are our registered trademarks or those of our affiliates, or trademarks for which we or our affiliates have pending registration applications or common law rights. This prospectus may also include trade names, trademarks and service marks of other
companies and organizations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc202221_2"></A>CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus, each prospectus supplement and the information incorporated by reference in this prospectus and each prospectus
supplement contain certain statements that constitute &#147;forward-looking statements&#148; within the meaning of Section&nbsp;27A of the Securities Act, as amended (the &#147;Securities Act&#148;) and Section&nbsp;21E of the Securities Exchange
Act of 1934, as amended (the &#147;Exchange Act&#148;). The words &#147;believe,&#148; &#147;may,&#148; &#147;will,&#148; &#147;potentially,&#148; &#147;estimate,&#148; &#147;continue,&#148; &#147;anticipate,&#148; &#147;intend,&#148;
&#147;could,&#148; &#147;would,&#148; &#147;project,&#148; &#147;plan,&#148; &#147;expect&#148; and the negative and plural forms of these words and similar expressions are intended to identify forward-looking statements, but are not the exclusive
means of identifying such statements. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements. Those statements appear in this prospectus, any accompanying prospectus supplement and
the documents incorporated herein and therein by reference, particularly in the sections titled &#147;Prospectus Summary&#148; and &#147;Risk Factors,&#148; and include statements regarding the intent, belief or current expectations of us and the
management that are subject to known and unknown risks, uncertainties and assumptions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Forward-looking statements reflect our current
views with respect to future events and are based on assumptions and subject to risks and uncertainties. Given these uncertainties, you should not place undue reliance on these forward-looking statements. We discuss many of these risks in greater
detail in our reports filed from time to time under the Securities Act and/or the Exchange Act, including the risks identified under the heading &#147;Risk Factors&#148; in our most recent Annual Report on Form
<FONT STYLE="white-space:nowrap">10-K</FONT> and our most recent Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> which are incorporated by reference into this prospectus in their entirety. We encourage you to read these filings
as they are made. Also, these forward-looking statements represent our estimates and assumptions only as of the date of the document containing the applicable statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus, any prospectus supplement and the information incorporated by reference in this prospectus and any prospectus supplement also
contain statements that are based on the current expectations of our company and management. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee that the future results, levels of
activity, performance or events and circumstances reflected in the forward-looking statements will be achieved or occur. You are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and
uncertainties, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Because forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, you
should not rely upon forward-looking statements as predictions of future events. The events and circumstances reflected in the forward-looking statements may not be achieved or occur and actual results could differ materially from those projected in
the forward-looking statements. Except as required by applicable law, including the securities laws of the United States and the rules and regulations of the SEC, we do not plan to publicly update or revise any forward-looking statements contained
herein after we distribute this prospectus, whether as a result of any new information, future events or otherwise. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc202221_3"></A>PROSPECTUS SUMMARY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>This summary description about us and our business highlights selected information contained elsewhere in this prospectus or incorporated
in this prospectus by reference. This summary does not contain all of the information you should consider before investing in our common stock. You should carefully read this entire prospectus and any applicable prospectus supplement, including each
of the documents incorporated herein or therein by reference, before making an investment decision. </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Overview </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">IRIDEX Corporation is a leading worldwide provider of therapeutic-based laser consoles, delivery devices and consumable instrumentation used to
treat sight-threatening eye diseases in ophthalmology. Certain of our products are powered by our differentiated MicroPulse technology, which is a method of delivering laser energy using a mode which chops the continuous wave laser beam into short,
microsecond-long laser pulses. Our products are sold in the United States predominantly through a direct sales force and internationally through independent distributors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Our products consist of laser consoles, delivery devices and consumable instrumentation, including laser probes, and are used in the treatment
of serious eye diseases, including glaucoma and retinal diseases. Our laser consoles consist of the following product lines: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Glaucoma</B>&nbsp;&#150; This product line includes our Cyclo G6 laser system used for the treatment of
glaucoma; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Medical Retina</B>&nbsp;&#150; Our medical retina product line includes our IQ 532 and IQ 577 laser
photocoagulation systems, which are used for the treatment of diabetic macular edema and other retinal diseases; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Surgical Retina</B>&nbsp;&#150; Our surgical retina line of products includes our OcuLight&nbsp;TX, OcuLight
SL,&nbsp;OcuLight SLx, OcuLight GL and OcuLight GLx laser photocoagulation systems. These systems&nbsp;are often used in vitrectomy procedures, which can be used to treat retinal diseases such as proliferative diabetic retinopathy,&nbsp;macular
holes, retinal tears and retinal detachments. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Our business generates recurring revenues through sales of consumable
products, predominantly <FONT STYLE="white-space:nowrap">single-use</FONT> laser probe devices and other instrumentation, as well as repair, servicing and extended service contracts for our laser systems. Our laser probes consist of the following
product lines: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Glaucoma</B>&nbsp;&#150; Probes used in our glaucoma product line include our patented MicroPulse P3
(&#147;MP3&#148;) probe <FONT STYLE="white-space:nowrap">and&nbsp;G-Probe;&nbsp;and</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Surgical Retina</B>&nbsp;&#150; Our surgical retina probes include our EndoProbe family of products used in
vitrectomy procedures. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Ophthalmologists typically use our laser systems in hospital operating rooms (&#147;ORs&#148;)
and ambulatory surgical centers (&#147;ASCs&#148;), as well as their offices and clinics. In the ORs and ASCs, ophthalmologists use our laser systems with either an indirect laser ophthalmoscope or a consumable, single use MP3 <FONT
STYLE="white-space:nowrap">probe,&nbsp;G-Probe&nbsp;or</FONT> EndoProbe. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Market Opportunity </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">We estimate that: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">there are 100&nbsp;million people worldwide with diabetes-related eye disease; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the G6 has a target installed base opportunity of 5,000 systems in the United States and approximately the same
number outside the United States for a total global installed based opportunity of 10,000 systems; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">there are 5&nbsp;million patients globally using multiple eye drop medications for the treatment of glaucoma;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">there is an opportunity to treat glaucoma <FONT STYLE="white-space:nowrap">patients&nbsp;4-6&nbsp;times</FONT>
with G6 probes during their lifetime; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the G6 probe target market opportunity is over $1&nbsp;billion. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Clinical Study Data </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The following
clinical results were observed in a study called &#147;Long-term Efficacy of Micropulse Diode Transscleral Cyclophotocoagulation in the Treatment of Refractory Glaucoma&#148; by investigators at the National University Health System, or NUHS, which
involved data from 14 patients treated using the MP3 probe over 78 months: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">39% mean intraocular pressure reduction from 43.3 to 24.8 millimeters of Mercury, or mmHg; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reduction in eyedrops from a mean of 1.8 to 1.1; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">average number of treatments was 3.6. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Corporate Information </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">IRIDEX Corporation
was incorporated in California in February&nbsp;1989 as IRIS Medical Instruments, Inc. In January&nbsp;1996, we changed our name to IRIDEX Corporation and reincorporated in Delaware. Our executive offices are located at 1212 Terra Bella Avenue,
Mountain View, California 94043-1824, and our telephone number is <FONT STYLE="white-space:nowrap">(650)&nbsp;940-4700.&nbsp;We</FONT> can also be reached at our website at www.iridex.com. Any information on, or that can be accessed through, our
website and social media channels is not part of this prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">IRIDEX, the IRIDEX logo, IRIS Medical, MicroPulse, OcuLight, SmartKey,
and EndoProbe are our registered <FONT STYLE="white-space:nowrap">trademarks.&nbsp;G-Probe,&nbsp;DioPexy,</FONT> DioVet, TruFocus, TrueCW, IQ 577, IQ 532, Cyclo G6, TxCell, OtoProbe, Symphony, EasyFit, Endoview, MoistAir and GreenTip product names
are our trademarks. All other trademarks or trade names appearing in this prospectus or incorporated by reference herein are the property of their respective owners. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The Offering </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">The Selling Stockholders
named in this prospectus may offer and sell up to 1,618,122 shares of our common stock, par value $0.01 per share. Our common stock is currently listed on The Nasdaq Global Market under the symbol &#147;IRIX.&#148; Shares of our common stock that
may be offered under this prospectus will be fully paid and <FONT STYLE="white-space:nowrap">non-assessable.</FONT> We will not receive any of the proceeds of sales by the Selling Stockholders of any of the common stock covered by this prospectus.
Throughout this prospectus, when we refer to the shares of our common stock being registered on behalf of the Selling Stockholders for offer and sale, we are referring to the shares that are being registered pursuant to the terms of the
(1)&nbsp;Investment Agreement, dated as of March&nbsp;2, 2021, by and among us and Topcon America Corporation, to which we issued and sold common stock in a private placement (the &#147;Investment Agreement&#148;), and (2)&nbsp;Registration Rights
Agreement, dated March&nbsp;2, 2021, by and among us and Topcon America Corporation (the &#147;Registration Rights Agreement&#148;; together with the Investment Agreement and the Registration Rights Agreement, the &#147;Agreements&#148;). When we
refer to the Selling Stockholders in this prospectus, we are referring to the holders of registration rights under the Agreements and, as applicable, their permitted transferees or other <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">successors-in-interest</FONT></FONT> that may be identified in a supplement to this prospectus or, if required, a post-effective amendment to the Registration Statement of which this prospectus is a part. See &#147;Selling
Stockholders&#148; beginning on page 11 of this prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc202221_4"></A><A NAME="cov202221_1"></A>RISK FACTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Investing in our common stock involves risks. Before deciding to invest in our common stock, please read carefully the risks and
uncertainties described below and incorporated by reference in this prospectus or any prospectus supplement. These risks and uncertainties include those discussed in our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the
fiscal year ended January&nbsp;2, 2021 and our Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the fiscal quarter ended April&nbsp;3, 2021, all of which are incorporated by reference and may be amended, supplemented or
superseded from time to time by other reports we file with the SEC in the future and any prospectus supplement related to a particular offering. See &#147;Information Incorporation by Reference&#148; and &#147;Where You Can Find More
Information.&#148; These risks are not the only risks that we may face. Additional risks and uncertainties that we are unaware of, or that we currently deem immaterial, may also become important factors that affect us. If any of the risks or
uncertainties described in this prospectus or our SEC filings or any such additional risks and uncertainties actually occur, our business, financial condition or results of operations could be materially and adversely affected which could cause our
actual operating results to differ materially from those indicated or suggested by forward-looking statements made in this prospectus or our SEC filings or presented elsewhere by management from time to time you could lose part or all of your
investment. In that case, the trading price of our common stock could decline and you could lose all or part of your investment. Please also see &#147;Cautionary Statement Regarding Forward-Looking Statements&#148; beginning on page 2. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The number of shares being registered for sale is significant in relation to the number of our outstanding shares of common stock. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have filed a Registration Statement of which this prospectus is a part to register the shares offered hereunder for sale into the public
market by the Selling Stockholders. These shares represent a large number of shares of our common stock, and if sold in the market all at once or at about the same time, could depress the market price of our common stock during the period the
Registration Statement remains effective and could also affect our ability to raise equity capital. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc202221_5"></A>USE OF PROCEEDS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are registering these shares pursuant to registration rights granted to the Selling Stockholders. We are not selling any securities under
this prospectus and we will not receive any of the proceeds from the sale or other disposition by the Selling Stockholders or their transferees of the shares of common stock covered hereby. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have agreed to pay all costs, expenses and fees relating to registering the shares of our common stock referenced in this prospectus. The
Selling Stockholders will pay any brokerage commissions and/or similar charges incurred in connection with the sale or other disposition by them of the shares covered hereby. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">See &#147;Selling Stockholders&#148; and &#147;Plan of Distribution&#148; described below. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc202221_6"></A>DESCRIPTION OF CAPITAL STOCK </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The following description of the capital stock is a summary. Because it is only a summary, it does not contain all the information that may be
important to you. For a complete description of the matters set forth, you should refer to our amended and restated certificate of incorporation, amended and restated bylaws and amended and restated investors&#146;&nbsp;rights agreement, each
previously filed with the Securities and Exchange Commission and incorporated by reference as an exhibit to the Annual Report on Form <FONT STYLE="white-space:nowrap">10-K,</FONT> and to the applicable provisions of Delaware law. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our authorized capital stock
consists of 30,000,000 shares of common stock, $0.01 par value per share, and 2,000,000&nbsp;shares of undesignated preferred stock, $0.01 par value per share. Our board of directors may establish the rights and preferences of the preferred stock
from time to time. As of June&nbsp;30, 2021, there were 15,761,996 shares of common stock issued and outstanding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In August 2007, we
filed a Certificate of Designation (the &#147;Certificate of Designation&#148;) authorizing us to issue up to 500,000 of preferred stock as shares of Series A Preferred Stock, par value $0.01 per share (&#147;Series A Preferred Stock&#148;), and we
issued 500,000 shares of Series A Preferred Stock, convertible into 1,000,000 shares of common stock, and warrants to purchase an aggregate of 600,000 shares of common stock at an exercise price of $0.01 per share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On June&nbsp;11, 2013, all outstanding shares of our Series A Preferred Stock automatically converted into 1,000,000 shares of common stock.
Pursuant to the Certificate of Designation, upon conversion into shares of common stock, the 500,000 shares of Series A Preferred Stock were cancelled and shall not be reissuable. The warrants were to expire on December&nbsp;31, 2007 but were
exercised prior to that date. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Common Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are authorized to issue up to 30,000,000 shares with a par value of $0.01 per share. There are no agreements or outstanding options,
warrants or similar rights that entitle their holder to acquire from us any of our equity securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Holders of shares of common stock
are entitled to one vote per share on all matters to be voted upon by the stockholders generally. Stockholders are entitled to receive such dividends as may be declared from time to time by the board of directors out of funds legally available
therefore. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Dividend Rights </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to preferences that may be applicable to any then outstanding preferred stock, holders of our common stock are entitled to receive
dividends, if any, as may be declared from time to time by our board of directors out of legally available funds. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Voting Rights
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There are 30,000,000&nbsp;shares of common stock authorized for issuance. Pursuant to our amended and restated certificate of
incorporation, each holder of our common stock is entitled to one vote for each share on all matters submitted to a vote of stockholders; provided, however, that, except as otherwise required by law, holders of our common stock, as such, shall not
be entitled to vote on any amendment to our amended and restated certificate of incorporation that relates solely to the terms of one or more outstanding series of preferred stock if the holders of such affected series are entitled, either
separately or together with the holders of one or more other such series, to vote thereon pursuant to our amended and restated certificate of incorporation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Pursuant to our amended and restated certificate of incorporation and amended and restated bylaws, corporate actions can generally be taken by a majority of our board of directors and/or
stockholders holding a majority of our outstanding shares, except as otherwise indicated in the section entitled &#147;Anti-takeover Effects of Delaware Law and Our Certificate of Incorporation and Bylaws.&#148; Additionally, our stockholders do not
have cumulative voting rights in the election of directors. Accordingly, holders of a plurality of the votes cast at a meeting of stockholders will be able to elect all of the directors then standing for election. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Right to Receive Liquidation Distributions </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event of our liquidation, dissolution or winding up, holders of our common stock are entitled to share ratably in the net assets legally
available for distribution to stockholders after the payment of all of our debts and other liabilities and the satisfaction of any liquidation preference granted to the holders of any then outstanding shares of preferred stock. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Rights and Preferences </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Holders of our common stock have no preemptive, conversion, subscription or other rights, and there are no redemption or sinking fund
provisions applicable to our common stock. The rights, preferences and privileges of the holders of our common stock are subject to, and may be adversely affected by, the rights of the holders of shares of any series of our preferred stock that we
may designate in the future. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our common stock is listed on The Nasdaq Global Market under the symbol &#147;IRIX&#148;. The transfer agent
and registrar for the common stock is Computershare Trust Company, N.A. Its address is 250 Royall Street, Canton, MA 02021. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Preferred Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our board of directors has the authority, without further action by our stockholders, to issue up to 1,500,000&nbsp;shares of preferred stock
in one or more series and to fix the rights, preferences, privileges and restrictions thereof. These rights, preferences and privileges could include dividend rights, conversion rights, voting rights, terms of redemption, liquidation preferences,
sinking fund terms and the number of shares constituting any series or the designation of such series, any or all of which may be greater than the rights of common stock. The issuance of preferred stock by us could adversely affect the voting power
of holders of common stock and the likelihood that such holders will receive dividend payments and payments upon liquidation. In addition, the issuance of preferred stock could have the effect of delaying, deferring or preventing a change of control
of our company or other corporate action. No shares of preferred stock are outstanding, and we have no present plan to issue any shares of preferred stock. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Registration Rights under our Amended and Restated Investors&#146; Rights Agreement, as Amended </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Investment funds affiliated with BlueLine Partners, L.L.C., which are collectively referred to as &#147;BlueLine,&#148; hold shares of our
common stock. BlueLine, or its permitted transferees, is entitled to rights with respect to the registration of such shares under the Securities Act. We refer to these shares as &#147;registrable securities.&#148; These rights are provided under the
terms of our amended and restated investors&#146; rights agreement between us and the holders of registrable securities, and include demand registration rights, &#147;piggyback&#148; registration rights and
<FONT STYLE="white-space:nowrap">Form&nbsp;S-3</FONT> registration rights. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These registration rights will terminate as to a given holder
of registrable securities when such holder&#146;s securities have been sold in a public securities transaction or when such securities may be sold without any restriction pursuant to Rule&nbsp;144(k). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Generally, we are required to pay the registration expenses (other than underwriters&#146; and brokers&#146; discounts and commissions) in
connection with the registrations described below, including up to $10,000 of reasonable </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
fees and disbursements of one counsel for the selling holder or holders of registrable securities. In an underwritten offering, the underwriters have the right to limit the number of shares
registered by the holders of registrable securities for marketing reasons, subject to certain limitations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Demand Registration
Rights </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the written request of holders of 60% or more of the then outstanding registrable securities that we file a
Registration Statement under the Securities Act, we will be obligated to notify all holders of registrable securities of such request and to use our reasonable best efforts to register the sale of all registrable securities that holders may request
to be registered. We are only obligated to file up to two Registration Statements in connection with underwritten offerings of the registrable securities in connection with the exercise of these demand registration rights. These demand registration
rights are subject to specified conditions and limitations, including the right of the underwriters to limit the number of shares included in any such registration under certain circumstances. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Piggyback Registration Rights </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we propose to register any of our securities under the Securities Act in connection with the public offering of such securities, the holders
of registrable securities will be entitled to certain &#147;piggyback&#148; registration rights allowing such holders to include their shares in such registration, subject to certain limitations. As a result, whenever we propose to file a
Registration Statement under the Securities Act, other than with respect to a registration related to either to the sale of securities to our employees pursuant to a stock plan, stock purchase or similar plan or a registration related to a corporate
reorganization or transaction under Rule 145 of the Securities Act, the holders of registrable securities are entitled to notice of the registration and have the right to include their shares in the registration. These registration rights are
subject to specified conditions and limitations, including the right of the underwriters to limit the number of shares included in any such Registration Statement under certain circumstances. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Form <FONT STYLE="white-space:nowrap">S-3</FONT> Registration Rights </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the written request from the holders of at least 60% of the then outstanding shares of registrable securities, holders of registrable
securities have the right to demand that we file a Registration Statement on <FONT STYLE="white-space:nowrap">Form&nbsp;S-3.</FONT> These registration rights are subject to specified conditions and limitations, including the right of the
underwriters to limit the number of shares included in any such Registration Statement under certain circumstances. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Anti-Takeover Effects of Delaware
Law and Our Certificate of Incorporation and Bylaws </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The provisions of Delaware law, our amended and restated certificate of
incorporation and our amended and restated bylaws may have the effect of delaying, deferring or discouraging another person from acquiring control of our company. These provisions, which are summarized below, may have the effect of discouraging
takeover bids. They are also designed, in part, to encourage persons seeking to acquire control of us to negotiate first with our board of directors. We believe that the benefits of increased protection of our potential ability to negotiate with an
unfriendly or unsolicited acquirer outweigh the disadvantages of discouraging a proposal to acquire us because negotiation of these proposals could result in an improvement of their terms. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Delaware Law </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We
are governed by the provisions of Section&nbsp;203 of the Delaware General Corporation Law (the &#147;DGCL&#148;). In general, Section&nbsp;203 prohibits a public Delaware corporation from engaging in a &#147;business combination&#148; with an
&#147;interested stockholder&#148; for a period of three years after the date of the transaction in which the person became an interested stockholder, unless the business combination is approved in a prescribed manner. A
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
&#147;business combination&#148; includes mergers, asset sales or other transactions resulting in a financial benefit to the stockholder. An &#147;interested stockholder&#148; is a person who,
alone or together with affiliates and associates, owns, or within three years of the date on which it is sought to be determined whether such person is an &#147;interested stockholder,&#148; did own, 15% or more of the corporation&#146;s outstanding
voting stock. These provisions may have the effect of delaying, deferring or preventing a change in our control. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Amended and
Restated Certificate of Incorporation and Amended and Restated Bylaw Provisions </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our amended and restated certificate of
incorporation and our amended and restated bylaws include a number of provisions that could deter hostile takeovers or delay or prevent changes in control of our management team, including the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Board of directors vacancies.</I><I></I><I>&nbsp;</I>Our amended and restated bylaws authorize only our board
of directors to fill vacant directorships, including newly created seats. In addition, the number of directors constituting our board of directors is permitted to be set only by a resolution adopted by our board of directors. These provisions
prevent a stockholder from increasing the size of our board of directors and then gaining control of our board of directors by filling the resulting vacancies with its own nominees. This makes it more difficult to change the composition of our board
of directors but promotes continuity of management. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Special meeting of stockholders</I>. Our amended and restated bylaws provide that special meetings of our
stockholders may be called only by our board of directors or by a committee of our board of directors, thus prohibiting a stockholder from calling a special meeting. These provisions might delay the ability of our stockholders to force consideration
of a proposal or for stockholders controlling a majority of our capital stock to take any action, including the removal of directors. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Advance notice requirements for stockholder proposals and director nominations</I>. Our amended and restated
bylaws provide advance notice procedures for stockholders seeking to bring business before our annual meeting of stockholders or to nominate candidates for election as directors at our annual meeting of stockholders. Our amended and restated bylaws
also specify certain requirements regarding the form and content of a stockholder&#146;s notice. These provisions might preclude our stockholders from bringing matters before our annual meeting of stockholders or from making nominations for
directors at our annual meeting of stockholders if the proper procedures are not followed. We expect that these provisions may also discourage or deter a potential acquirer from conducting a solicitation of proxies to elect the acquirer&#146;s own
slate of directors or otherwise attempting to obtain control of our company. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>No cumulative voting</I>. The DGCL provides that stockholders are not entitled to the right to cumulate votes
in the election of directors unless a corporation&#146;s certificate of incorporation provides otherwise. Our amended and restated certificate of incorporation does not provide for cumulative voting. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Issuance of undesignated preferred stock</I>. Our board of directors has the authority, without further action
by the stockholders, to issue up to 1,500,000 shares of undesignated preferred stock with rights and preferences, including voting rights, designated from time to time by our board of directors. The existence of authorized but unissued shares of
preferred stock would enable our board of directors to render more difficult or to discourage an attempt to obtain control of us by means of a merger, tender offer, proxy contest or other means. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc202221_7"></A>SELLING STOCKHOLDERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the Agreements, we agreed to file the Registration Statement of which this prospectus forms a part to cover the resale of the
shares issued to the Selling Stockholders and to keep such Registration Statement effective for the periods set forth in the Registration Rights Agreement as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Investment Agreement</I></B><I>.</I><I></I><I>&nbsp;</I>On March&nbsp;2, 2021, we entered into an
Investment Agreement with the Selling Stockholders listed in the table below pursuant to which we issued and sold in a private placement a total of 1,618,122 shares of common stock (the &#147;Shares&#148;), for a total purchase price of
approximately $10&nbsp;million.&nbsp;In connection with this agreement we also agreed to execute the Registration Rights Agreement described below. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Registration Rights Agreement</I></B><I>.</I><I></I><I>&nbsp;</I>In connection with the private placement
of shares of our common stock described above, we entered into a Registration Rights Agreement with Topcon America Corporation, pursuant to which we agreed to file a Registration Statement of which this prospectus forms a part to cover the resale of
the Shares.&nbsp;We also agreed to keep such Registration Statement effective until the date on which all of the Shares registered for sale or resale under this Registration Statement are either sold pursuant to the Registration Statement or can be
sold publicly without restriction or limitation under Rule&nbsp;144 under the Securities Act of 1933 (the &#147;Securities Act&#148;). </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Registration of Shares under the Agreements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are registering the Shares in accordance with the terms of the corresponding Agreements to permit each of the Selling Stockholders
identified below, or their permitted transferees or other <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">successors-in-interest</FONT></FONT> that may be identified in a supplement to this prospectus or, if required, a
post-effective amendment to the Registration Statement of which this prospectus is a part, to sell, resell or otherwise dispose of the Shares in a manner contemplated under &#147;Plan of Distribution&#148; in this prospectus (as may be supplemented
and amended). Throughout this prospectus, when we refer to the Selling Stockholders in this prospectus we are referring to the holders of registration rights under the Agreements and, as applicable, their permitted transferees or other <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">successors-in-interest</FONT></FONT> that may be identified in a supplement to this prospectus or, if required, a post-effective amendment to the Registration Statement of which this
prospectus is a part. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Selling Stockholders may sell some, all or none of their Shares. We do not know how long the Selling
Stockholders will hold the Shares before selling them, and we currently have no agreements, arrangements or understandings with the Selling Stockholders regarding the sale or other disposition of any of the Shares. The Shares covered hereby may be
offered from time to time by the Selling Stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth the names of the Selling Stockholders, the number
and percentage of our common stock beneficially owned by the Selling Stockholders as of June&nbsp;30, 2021, the number of Shares that may be offered under this prospectus, and the number and percentage of our common stock beneficially owned by the
Selling Stockholders assuming all of the Shares covered hereby are sold. Beneficial ownership is determined in accordance with the rules of the SEC and includes voting or investment power with respect to our common stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All information contained in the table below and the footnotes thereto is based upon information provided to us by the Selling Stockholders
under this prospectus. The percentage of our shares owned after the offering is based on 15,761,996 shares of common stock outstanding as of June&nbsp;30, 2021. Unless otherwise indicated in the footnotes to this table, we believe that the Selling
Stockholders named in this table has sole voting power with respect to the shares of common stock indicated as beneficially owned. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The address for the Selling Stockholders listed on the table below is 111 Bauer Drive,
Oakland, NJ 07436. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Beneficial&nbsp;Ownership&nbsp;Prior</B><br><B>to the Offering</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares Beneficially Owned<BR>After Offering</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name of Selling Stockholder<SUP
STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Shares<BR>Beneficially<BR>Owned&nbsp;Prior<BR>to the<BR>Offering<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percentage<BR>of<BR>Outstanding<BR>Common<BR>Stock<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Shares&nbsp;Being<BR>Registered<BR>Hereby<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Shares<BR>Beneficially<BR>Owned&nbsp;After<BR>the<BR>Offering<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percentage<BR>of<BR>Outstanding<BR>Common<BR>Stock<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Topcon America Corporation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,618,122</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.3</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,618,122</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.00</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,618,122</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>10.3</B></TD>
<TD NOWRAP VALIGN="bottom"><B>%&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,618,122</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>0.00</B></TD>
<TD NOWRAP VALIGN="bottom"><B>%&nbsp;</B></TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Information concerning named Selling Stockholders or future transferees, pledgees, assignees, distributees,
donees or successors of or from any such stockholder or others who later hold any Selling Stockholders&#146; interests will be set forth in supplements to this prospectus, absent circumstances indicating that the change is material. In addition,
post-effective amendments to the Registration Statement of which this prospectus forms a part will be filed to disclose any material changes to the plan of distribution from the description in the final prospectus. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Beneficial ownership is determined in accordance with the rules and regulations of the SEC. In computing the
number of shares beneficially owned by a person and the percentage ownership of that person, securities that are currently convertible or exercisable into shares of our common stock, or convertible or exercisable into shares of our common stock
within 60 days of June&nbsp;30, 2021 are deemed outstanding. Such shares, however, are not deemed outstanding for the purposes of computing the percentage ownership of any other person. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Based on 15,761,996 shares of common stock outstanding as of June&nbsp;30, 2021. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Assumes the sale of all shares being offered pursuant to this prospectus. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc202221_8"></A>PLAN OF DISTRIBUTION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are registering the shares of common stock issued to the Selling Stockholders to permit the sale and resale of these shares of common stock
by the Selling Stockholders from time to time from after the date of this prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each Selling Stockholder of the securities and any
of their pledgees, assignees and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">successors-in-interest</FONT></FONT> may, from time to time, sell any or all of their securities covered hereby on The Nasdaq Global Market or any
other stock exchange, market or trading facility on which the securities are traded or in private transactions.&nbsp;Sales of the common stock to be registered hereunder could be made at prevailing market prices at the time of the sale, at fixed
prices, at negotiated prices, or at varying prices determined at the time of sale. As a result, we cannot know the price at which any of our common stock to be registered hereunder may ultimately be sold by the holders thereof. A Selling Stockholder
may use any one or more of the following methods when selling securities: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">block trades in which the broker-dealer will attempt to sell the shares as agent but may position and resell a
portion of the block as principal to facilitate the transaction; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">purchases by a broker-dealer as principal and resale by the broker-dealer for its account; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an exchange distribution in accordance with the rules of the applicable exchange; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">privately negotiated transactions; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">settlement of short sales, to the extent permitted by law; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in transactions through broker-dealers that agree with the Selling Stockholders to sell a specified number of
such securities at a stipulated price per security; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">through the writing or settlement of options or other hedging transactions, whether through an options exchange
or otherwise; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a combination of any such methods of sale; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any other method permitted pursuant to applicable law. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Selling Stockholders may, from time to time, pledge or grant a security interest in some or all of the shares of common stock owned by
them and, if they default in the performance of their secured obligations, the pledgees or secured parties may offer and sell the shares of common stock, from time to time, under this prospectus, or under an amendment to this prospectus under Rule
424(b)(3) or other applicable provision of the Securities Act amending the list of Selling Stockholders to include the pledgee, transferee or other successors in interest as Selling Stockholders under this prospectus. The Selling Stockholders may
also sell securities under Rule&nbsp;144 under the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), if available, rather than under this prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Broker-dealers engaged by the Selling Stockholders may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive
commissions or discounts from the Selling Stockholders (or, if any broker-dealer acts as agent for the purchaser of securities, from the purchaser) in amounts to be negotiated, but, except as set forth in a supplement to this prospectus, in the case
of an agency transaction not in excess of a customary brokerage commission in compliance with FINRA Rule&nbsp;2440; and in the case of a principal transaction a markup or markdown in compliance with FINRA
<FONT STYLE="white-space:nowrap">IM-2440.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The aggregate proceeds to the Selling Stockholders from the sale of the common stock
offered by them will be the purchase price of the common stock less discounts or commissions, if any. Each of the Selling Stockholders reserves the right to accept and, together with their agents from time to time, to reject, in whole or in part,
any proposed purchase of common stock to be made directly or through agents. We will not receive any of the proceeds from the sale by the Selling Stockholders of the shares of common stock. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the sale of the securities or interests therein, the Selling Stockholders
may enter into hedging transactions with broker-dealers or other financial institutions, which may in turn engage in short sales of the securities in the course of hedging the positions they assume. The Selling Stockholders may also sell securities
short and deliver these securities to close out their short positions, or loan or pledge the securities to broker-dealers that in turn may sell these securities. The Selling Stockholders may also enter into option or other transactions with
broker-dealers or other financial institutions or create one or more derivative securities which require the delivery to such broker-dealer or other financial institution of securities offered by this prospectus, which shares such broker-dealer or
other financial institution may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Selling
Stockholders and any broker-dealers or agents that are involved in selling the securities may be deemed to be &#147;underwriters&#148; within the meaning of the Securities Act in connection with such sales.&nbsp;In such event, any commissions
received by such broker-dealers or agents and any profit on the resale of the securities purchased by them may be deemed to be underwriting commissions or discounts under the Securities Act.&nbsp;Selling Stockholders who are &#147;underwriters&#148;
within the meaning of Section&nbsp;2(11) of the Securities Act will be subject to the prospectus delivery requirements of the Securities Act and may be subject to certain statutory liabilities of, including but not limited to, Sections&nbsp;11, 12
and 17 of the Securities Act and <FONT STYLE="white-space:nowrap">Rule&nbsp;10b-5</FONT> under the Exchange Act. Each of the Selling Stockholders has informed us that it is not a registered broker-dealer or an affiliate of a registered
broker-dealer, and it does not have any written or oral agreement or understanding, directly or indirectly, with any person to distribute the securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are required to pay certain fees and expenses incurred by us incident to the registration of the securities.&nbsp;We have agreed to
indemnify the Selling Stockholders against certain losses, claims, damages and liabilities, including liabilities under the Securities Act, and the Selling Stockholders may be entitled to contribution. We may be indemnified by the Selling
Stockholders against certain losses, claims, damages and liabilities, including liabilities under the Securities Act that may arise from any written information furnished to us by the Selling Stockholders specifically for use in this prospectus, or
we may be entitled to contribution. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Because Selling Stockholders may be deemed to be &#147;underwriters&#148; within the meaning of the
Securities Act, they will be subject to the prospectus delivery requirements of the Securities Act including Rule 172 thereunder.&nbsp;In addition, any securities covered by this prospectus which qualify for sale pursuant to Rule 144 under the
Securities Act may be sold under Rule 144 rather than under this prospectus. The Selling Stockholders have advised us that there is no underwriter or coordinating broker acting in connection with the proposed sale of the resale securities by the
Selling Stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We agreed to keep this prospectus effective until the earlier of (i)&nbsp;the date on which the securities may be
resold by the Selling Stockholders without registration and without regard to any volume or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">manner-of-sale</FONT></FONT> limitations by reason of Rule 144, without the requirement for
us to be in compliance with the current public information under Rule 144 under the Securities Act or any other rule of similar effect or (ii)&nbsp;all of the securities have been sold pursuant to this prospectus or Rule 144 under the Securities Act
or any other rule of similar effect.&nbsp;The resale securities will be sold only through registered or licensed brokers or dealers if required under applicable state securities laws. In addition, in certain states, the resale securities covered
hereby may not be sold unless they have been registered or qualified for sale in the applicable state or an exemption from the registration or qualification requirement is available and is complied with. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under applicable rules and regulations under the Exchange Act, any person engaged in the distribution of the resale securities may not
simultaneously engage in market making activities with respect to the common stock for the applicable restricted period, as defined in Regulation M, prior to the commencement of the distribution.&nbsp;In addition, the Selling Stockholders will be
subject to applicable provisions of the Exchange Act and the rules and regulations thereunder, including Regulation M, which may limit the timing of purchases and sales of securities of the common stock by the Selling Stockholders or any other
person.&nbsp;We will make copies of this prospectus available to the Selling Stockholders and have informed them of the need to deliver a copy of this prospectus to each purchaser at or prior to the time of the sale (including by compliance with
Rule 172 under the Securities Act). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">There can be no assurance that any Selling Stockholder will sell any or all of the shares of
common stock we registered on behalf of the Selling Stockholders pursuant to the Registration Statement of which this prospectus forms a part. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Once sold under the Registration Statement of which this prospectus forms a part, the shares of common stock will be freely tradable in the
hands of persons other than our affiliates. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc202221_9"></A>LEGAL MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The validity of the common stock offered by this prospectus will be passed upon by Wilson Sonsini Goodrich&nbsp;&amp; Rosati, P.C., Palo Alto,
California. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc202221_10"></A>EXPERTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The consolidated financial statements of IRIDEX Corporation as of January&nbsp;2, 2021 and December&nbsp;28, 2019 and for each of the two
years in the period ended January&nbsp;2, 2021 incorporated in this prospectus by reference to the Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended January&nbsp;2, 2021, have been so incorporated in reliance on
the report of BPM LLP, an independent registered public accounting firm, given on the authority of said firm as experts in auditing and accounting. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc202221_11"></A>WHERE YOU CAN FIND MORE INFORMATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We file annual, quarterly and other reports, proxy statements and other information with the SEC. Our SEC filings are available to the public
over the Internet at the SEC&#146;s website at http://www.sec.gov. You may also read and copy any document we file at the SEC&#146;s Public Reference Room at 100 F Street, NE, Washington, D.C. 20549. Please call the SEC at <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-800-SEC-0330</FONT></FONT></FONT> for further information on the Public Reference Room. Our Annual Report on Form
<FONT STYLE="white-space:nowrap">10-K,</FONT> Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q,</FONT> and Current Reports on Form <FONT STYLE="white-space:nowrap">8-K,</FONT> including any amendments to those reports, and other
information that we file with or furnish to the SEC pursuant to Section&nbsp;13(a) or 15(d) of the Exchange Act can also be accessed free of charge through the Internet. These filings will be available as soon as reasonably practicable after we
electronically file such material with, or furnish it to, the SEC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have filed with the SEC a Registration Statement under the
Securities Act relating to the offering of these securities. The Registration Statement, including the attached exhibits, contains additional relevant information about us and the securities. This prospectus does not contain all of the information
set forth in the Registration Statement. You can obtain a copy of the Registration Statement, at prescribed rates, from the SEC at the address listed above. The Registration Statement and the documents referred to below under &#147;Information
Incorporated by Reference&#148; are also available on our website, www.iridex.com. We have not incorporated by reference into this prospectus the information on, or that can be accessed through, our website, and it is not a part of this prospectus.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc202221_12"></A>INFORMATION INCORPORATED BY REFERENCE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The SEC allows us to incorporate by reference into this prospectus certain information we file with it, which means that we can disclose
important information by referring you to those documents. The information incorporated by reference is considered to be a part of this prospectus, and information that we file later with the SEC will automatically update and supersede information
contained in this prospectus and any accompanying prospectus supplement. We incorporate by reference the documents listed below that we have previously filed with the SEC (excluding any portions of any Form
<FONT STYLE="white-space:nowrap">8-K</FONT> that are not deemed &#147;filed&#148; pursuant to the General Instructions of Form <FONT STYLE="white-space:nowrap">8-K):</FONT> </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/1006045/000156459021014859/irix-10k_20210102.htm">Form
 <FONT STYLE="white-space:nowrap">10-K</FONT></A> for the fiscal year ended January&nbsp;2, 2021, filed on March&nbsp;
23, 2021, including the information specifically incorporated by reference into the Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/1006045/000156459021014859/irix-10k_20210102.htm">Form
<FONT STYLE="white-space:nowrap">10-K</FONT></A> from our definitive proxy statement on <A HREF="http://www.sec.gov/Archives/edgar/data/1006045/000117494721000460/def14a-50502_irix.htm">Schedule&nbsp;14A</A>, filed on April&nbsp;30, 2021;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our Quarterly Report on <A HREF="http://www.sec.gov/Archives/edgar/data/1006045/000156459021026981/irix-10q_20210403.htm">Form
 <FONT STYLE="white-space:nowrap">10-Q</FONT></A> for the fiscal quarter ended April&nbsp;3, 2021, filed with the SEC on May&nbsp;12, 2021; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our Current Reports on Form <FONT STYLE="white-space:nowrap">8-K</FONT> filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/1006045/000156459021010314/irix-8k_20210301.htm">March&nbsp;2,
 2021</A> as amended on Form <FONT STYLE="white-space:nowrap">8-K/A</FONT> on <A HREF="http://www.sec.gov/Archives/edgar/data/1006045/000156459021010940/irix-8ka_20210302.htm">March&nbsp;
4, 2021</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1006045/000156459021012049/irix-8k_20210310.htm">March&nbsp;10, 2021</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1006045/000156459021014612/irix-8k_20210322.htm">March&nbsp;
22, 2021</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1006045/000156459021033622/irix-8k_20210616.htm">June&nbsp;21, 2021</A>, and <A HREF="http://www.sec.gov/Archives/edgar/data/1006045/000156459021035076/irix-8k_20210629.htm">June&nbsp;
29, 2021</A>; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the description of our common stock contained in the Registration Statement on Form <FONT
STYLE="white-space:nowrap">8-A</FONT> relating thereto, including any amendment or report filed for the purpose of updating such description. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We also incorporate by reference into this prospectus additional documents that we may file with the SEC under Sections&nbsp;13(a), 13(c), 14
or 15(d) of the Exchange Act prior to the completion or termination of the offering, including all such documents we may file with the SEC after the date of the initial Registration Statement and prior to the effectiveness of the Registration
Statement, but excluding any information deemed furnished and not filed with the SEC. Any statements contained in a previously filed document incorporated by reference into this prospectus is deemed to be modified or superseded for purposes of this
prospectus to the extent that a statement contained in this prospectus, or in a subsequently filed document also incorporated by reference herein, modifies or supersedes that statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus may contain information that updates, modifies or is contrary to information in one or more of the documents incorporated by
reference in this prospectus. You should rely only on the information incorporated by reference or provided in this prospectus. We have not authorized anyone else to provide you with different information. You should not assume that the information
in this prospectus is accurate as of any date other than the date of this prospectus or the date of the documents incorporated by reference in this prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will provide to each person, including any beneficial owner, to whom this prospectus is delivered, upon written or oral request, at no cost
to the requester, a copy of any and all of the information that is incorporated by reference in this prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Requests for such
documents should be directed to: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">IRIDEX Corporation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1212 Terra Bella Avenue, </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Mountain
View, California 94043 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Attention: Interim Chief Financial Officer </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You may also access certain of the documents incorporated by reference in this prospectus through our website at www.iridex.com. Except for
the specific incorporated documents listed above, no information available on, or that can be accessed through, our website shall be deemed to be incorporated by reference into this prospectus or the Registration Statement of which it forms a part.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="font-size:72pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:30pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:30pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g202221g27l21.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:30pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:30pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:72pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g202221g03a20.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g202221g03a20.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2+"4&AO=&]S:&]P(#,N,  X0DE-! 0
M    (J:^B' X0DE-! 0      %D< @   @  ' )0  AR<C,W-S Q,QP"!0!
M36EC<F]S;V9T(%=O<F0@+2!)<FED97@@+2!&;W)M(%,M,R M7T1204947R T
M.#0T+34X-#8M-3(V-"!V+C4N9  X0DE-!"4      !#TT;!  [>F&#//P5VK
M(7]U.$))300Z      #E    $     $       MP<FEN=$]U='!U=     4
M    4'-T4V)O;VP!     $EN=&5E;G5M     $EN=&4     0VQR;0    ]P
M<FEN=%-I>'1E96Y":71B;V]L      MP<FEN=&5R3F%M951%6%0    !
M   /<')I;G10<F]O9E-E='5P3V)J8P    P 4 !R &\ ;P!F "  4P!E '0
M=0!P       *<')O;V93971U<     $     0FQT;F5N=6T    ,8G5I;'1I
M;E!R;V]F    "7!R;V]F0TU92P X0DE-!#L      BT    0     0
M$G!R:6YT3W5T<'5T3W!T:6]N<P   !<     0W!T;F)O;VP      $-L8G)B
M;V]L      !29W--8F]O;       0W)N0V)O;VP      $-N=$-B;V]L
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M8W)O<%)E8W1";W1T;VUL;VYG          QC<F]P4F5C=$QE9G1L;VYG
M      UC<F]P4F5C=%)I9VAT;&]N9P         +8W)O<%)E8W14;W!L;VYG
M       X0DE- ^T      ! #O_XU  (  0.__C4  @ !.$))300F       .
M             #^    X0DE-! T       0   !:.$))3009       $
M'CA"24T#\P      "0           0 X0DE-)Q        H  0         !
M.$))30/U      !( "]F9@ ! &QF9@ &       ! "]F9@ ! *&9F@ &
M   ! #(    ! %H    &       ! #4    ! "T    &       !.$))30/X
M      !P  #_____________________________ ^@     ____________
M_________________P/H     /____________________________\#Z
M  #_____________________________ ^@  #A"24T$"       $     $
M  )    "0      X0DE-!!X       0     .$))300:      -!    !@
M            KP   +L    & %, 5 !? #  ,  S     0
M           !              "[    KP                     !
M                     !     !        ;G5L;     (    &8F]U;F1S
M3V)J8P    $       !28W0Q    !     !4;W @;&]N9P          3&5F
M=&QO;F<          $)T;VUL;VYG    KP    !29VAT;&]N9P   +L    &
M<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E    $@    =S;&EC
M94E$;&]N9P         '9W)O=7!)1&QO;F<         !F]R:6=I;F5N=6T
M   ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960     5'EP965N=6T
M   *15-L:6-E5'EP90    !);6<@    !F)O=6YD<T]B:F,    !
M4F-T,0    0     5&]P(&QO;F<          $QE9G1L;VYG          !"
M=&]M;&]N9P   *\     4F=H=&QO;F<   "[     W5R;%1%6%0    !
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M3001       ! 0 X0DE-!!0       0    $.$))300,     !@@     0
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M4VTWN_\ "_4[7_\ !K&J^J6=F]$QNKX]=.4S(H;>[%V;;1N&[TZMV^O(V_\
M6=ZYR_HW3LFN6-]+<)#F:M/]:I_M2&#BO@D)5T^5!S<-<43&^N[['TWK73^I
M.?7CV%N34 ;\2UIJOKD _IL6X,N8WW>VS;Z5G^#L5]>&5=1ZMTCT69F[-PJ)
M&-:'EE^.7#;NP,[W78;]/Z/;ZW3[_P#"4KTOZM?6RK/IQF9-S;FY,UXV<&^F
M++6C=9@YU&K<'JK&_I/1_HV95^LX/Z/]#5$8F)HBBR @BP;#U"2:4Z"5))))
M*4DDDDI__]#U5))))2EG=<ZI9T["#L>OU\[(>*,&@@P^Y\[?4V_1HHK;9DY5
MG^#QJ;5HKS'_ !A=<)?E&O4M+^E8?!VRRG)ZWEC=7]-[+<7I-6VSV?KG^DV)
M*>9ZCE6]:S785&2^_ HL-V1F. :[)O/LMZC96/;^D_F>FX_T,3"_ZXKS6TXN
M.6UMV55-)VCR&I_E/=^\I=!Z;CUW8F#D6&JN^P-R+&P#N>"*J][MWI-]7TZ/
M5V?V%U.1]3>FO;]CLOOZ=EV^QAN<,BBP.]FVFW;C[K'?FUN?CY'_  #ZU:@8
MX14@>.0NVO(2RZQ(X0:I*[_%Z7],<'9CF]2>S40/LX<1_,[0WU_3_P 'Z_J[
M_P##>G_@5V-53:L=M31M;6P-#1P !MA Z5D95^$PYM?I9E<UY+!.WU&>USZG
M.#-]-O\ .T_\'8BV96,RYF,^QHON:YU=4^YS61ZCPW]QFYNYRKRG*1]1MFC&
M,=A3E_4W_P 2G2?_  K7_P!2%F'ZA57VYE^1E.J??=;9CLH#?3K:][K*_5;:
MPNM=[OTC6.I_T5?^D5_ZGY..SZM]&QGV-;?;AL?563#G-8UOJ.K;^?Z>]F_:
MMG)R&8]%E[FN>*VEVU@W.='YC&#Z3W_18EQ2B3PFE<((%BWR6ZEU5M^+>&N?
M2]]-P&K"6$UO^E^8[:LEMEO0<IUM0=;TS, KR\:?I-:?48&O_P 'E8SOT_3<
MO^=HN_ZXN\'U7ILMLLZE=;?U/*<;W]/P2UHJ=:?5>V_)=N_1LW^VZS[/ZG^!
MJLL6#]8>DXV+EV=,#RYII8<ACG>IZ5KRY[6LOV4.LVU^E=[J59,H9@(Z\8&A
M\6$1EB)EIPWMX/>?5;K)ZCB>C=<W)R*&,>,EC2QN11:"[$SVL(&QUS664Y57
M^ SL?*J_F]BW%X_]2NKOZ9DFFXG=TI[BYW8X61;51U"H_2VMQ,I^-U>K;_W>
M_P!*O7U4\&PNDDDDI22222G_T?54DDDE*7B'6+;,OJ/1Z[7;A90<ZQG8/S;\
MCJEA_M4NQ?\ MM>W.$M(\1"\-RFEO6>D//T;.F86T_U<;[.\?V;:GL3H"YQ\
MPB7RR\BZE.-?F7-Q:*CD77RUM0C73W;B[VL8UOTWO7?=)Z3]8ZL8XW4\W&RL
M<C;Z-M3KW1^X_*?9C^LS_C<?>N.Z!U4](ZK7E^B[(%C'8SJ:Q-CO4=6]OH,_
MPEV^EOZ->FT6&VFNUU;Z2]H<:K-N]LCZ%GINL9O;_)L4_-2/$(UIN&'EXCAL
M'7JT+*,CIE;K<:X/Q*FES\?)? 8UH]WH9;]SJVM_T>3ZE7_"XS%S/U9ZK7U#
MZX9V8]YG*H>S%%@VN%53V>G4QI_-]/\ 6/;_ ,*MWZV8;<S!IJR<IF%TQEPM
MZA<YVTFM@<ZNJO<#6YS\CT?YS_SXL&NG'S:B[ZN].JZ?@5!SW_6'-:?4#!N]
M2[ ]5WVQWL_[4VW55J"-<)[G\&4W8<_J&6,?ZJ?5
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MUMOUY\X^3&W_ $\IBW_<2WNSL7^A;\#DTP>T +W@)BBD40* \>3 8GD1$ ,
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MD6:2HFT2B<!DKGS1W9M0I+YY:BRK7#L";,][[Q=FH3/'_EIDN3+RJ*9.9O\
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M0#I([S&^MV #1RKM$PHSBG$I)$LTQ$Q1RDE10H*:QMIX_:+A>SW-^^G?9C6
MVIXFN%+P+1L)5: JV5LTM7RTCE*?K[A!TA6W=2ACG2,P/*1T8YC7$LGPT1?(
M/$0<.%$56[37.),'3PYB6(5%7+,R5/GS33)RM+&9U)+EPP=@-R+/H,Q@F*G'
MJ.CD25I2J1(0)G>8LGN%VNW[B'9V<@D.[K:IT_-O>T] \Q4H5Q<LI2PJ.K-F
M.^+)SF09Z2><'D'?S9T14\<1T/<8[=@)#'3$4G"ZQ1Y#2IV)SJF4D&:B6C-_
MCEN "!H[%+GE9_I&W(HI4M2605*2&*P3J&<A/W;GH7B=*7:0PIIEX$ Y$!\
M4!XY /OYX_JB8"\"7_H@&OB*5/F#E[9MK@$ZDW+:,W6]_J&4=T,&'RLS Z6V
M'AHS,(^SB;O((D\% 1[@'Z@)1#Z< '@>>?H(^W(ZJ.>UANX??;TN\+%QX/\
M@_34:-$;]T0";%J?Z"F ;M0C&,'!^PHVN.$HAV\F'[^W'GN#VXU24E3'*D*!
MU(U#^O*]QK!U!\I=[-R?6_,VUTTY")%D @"81#@1X[OH8? ![B!0Y\@ ^P&]
MP#GSJLJ<Y5J#'Y0;,-6?Q>P\N40$@ D)8Z\[D<R?R'8QR43%,("4.TP"(#W<
MB'(!Y'D X_YAJD"4G13JN;ESK;^A=N@O!YA^9(;0$%OZ][1^&6C(R88/H>79
M,Y.+DD%&4A'2#9)XR=M5T0(LW=MW!#H+MUBB)54EB&3,03=Q>#:DS52E)4D@
M+>Q38IU8L-.;NP!;:(R)4%)4"I.X4Y27 ?H"=_[:$^9BZ7[BD7&4SKL&R9([
M9<M"O\SDJ,T$[C#=\=H%$48^<K)%"(QR+]000$R0+-BE6$Z;<B:8('RZ,4,Q
M2)%>]1+78J"<RTC4D%K$^1MYC%KH/AA4^D/P5@V!?*HBXS ,XN+/=/.*\?4&
MWNY<W#SD7![@*W3Z5*;80O=0M:M(G?GE;L=U82#5C:)^/7*<R!4XL\'\L:IM
MUE/2</91%9-F8I6:/;. \(1@-)B/$"YADR)U*DTJ9H*9A0I.9"BHFY*2"0PN
MSAP(Y1Q;BDS&ZFCP=,LF?)GJ3-6@DH*DJ"5$) +)*@2 ZFV)A,W3UC6V4=W5
MTW?Y"B%)3%.U&'>9ZL+,Z9E4INV1SDM=P!C%F0I5O7E+_E5_5(=E'"F)74<R
MG1$" U,8O&.(<25C&+5U?\3,4=U"'*E$/J"&L][C=B7$=:P.BE8?12:8)<K2
M HBV4L"7<>;MU:-C]T^L%S.W_:EC*HW(#'R=9&C[*.8':A2%</,KY->*6Z[F
M<"01 QV,I(C$)F[C"9M&MP$>  -877IIKZ^_ ^,9._3I$T]3$P:0@TA!I"#2
M$&D(-(0#[#]-0=#X&$1OW5[=H?=!@BZ8@DI=S6)B5;LINA7F,*)9G'>3:J_1
ML./<@PITU$U22=3M+"-EDRIK)BY11<,S*$3=*:I1W4LIG8NX\GN2W31_6(NX
M(+$$'4C0OY^<:]SJ\;9KJ2UJ;ZJK5CU')L1<T<<[W:1"H*=F.-SU;(BBODAB
MD"0$0QIG./(QMM5DDDD6#I5VY1474=.7)6_U8?B,_"ZF752%*2)4Q*RRLI[I
MLY8L^CD#[Q:KL.DU]*JD64J^,E096A<::V8M<:6>/Z[(]Y%\K4I!9KPM<EJ/
MEJL-31-B*GZ+YE),7*K922@;-!+F^$L52L:K%!TNR=D!,KUDRD(E:)G8AC)-
M/1N$RL+[1\%,NOF2T5,M(*2M0406 />!01S#"Y TU/!\07B/ 6*E4A"URIA*
M1W"93*+.?F!(! #@,[EQJ_+^[V;@!J"<6.!L6ENP-BI&N 7"R#!_$ 4W]^DH
MI( 7OHG/P8(O\Z',!!%,DCX*.M3_ /AE,Z?.1-J0F53E2Y92G,I3'NEPI 9M
M&S 7MRV(=IPR2Q+DRS,6$A;DI;H!E5NY<^@UALG21S[DW<GMYNN5LR9%1O5^
MFLU7EG(Q;./C82*QW%0["MQU>ID+"1B12L(L\0@VM*"D@XDY5T-F.=]+R*J8
M.#<SXDPV5A-:NA25%,D!BQ23=6^93FP+.0,Q9KQT# L2F8K3"J4@)*B0P();
MNERR0-SJ!L-!><>?MQ&+ML^-9_*.5)]"%KT&R6720 Y59>>D"$Y:05?CNXKB
M6FI%<4FK)@V RBJRQ -VE$3:P]+2S9Z3\!"I@2 5$ V!=GU;?_6F2J:R32M\
M=:4!1(#D D\@'&CW9V%[1 ?%UKM&9=HS3<W>2+-+'N+R13[M"5SXL7;:B8N;
M7PS'%=+8K  -W!VU9_[)IZ323(K(VFU3J@*"Q2CT&U$T+E$I6"%)+%*K$=.G
M2W\Q>DS$S$I6@@I(!!W+V)/BVQ)W<1WEPW7U_:5O@1P5EN8^5X<W(UQOD/&5
MRE70_*J+E)Q+OX&W469=.1-\#7+6Z9Q=DA7RZY6D?9YUY$<-6;R+2+]4J@7.
MIUSY:%3%)604@$LD!*C>Y<$@N!9]R08M3:Q"9J$+*4)* ZR0.\Z@ 0PLP -]
MK,(9^1R5=--PB=-5%8A5"*I'*JF=,P 9,Z2A/T*)J@("F8IA Y1 Q1\\:^ (
M3<K24J!8!3O8LUVTNUKC6+Y)=(0<R5!\P8@:L1=BXL7N-GBMWO+ZEVX39[OB
MRI2:+/5?,&)E8B@V!SCJYD*U5HM@D*ZV0F:[5[A!-59"(*L5HULS]A-QUD])
MQ9#"U(P(4$0Z;POP"OB+#Q6%"Y+J7EG$.%95J0"Q8!(RV;<?,Y(.@\0<9(P6
MM-(&F:/< )S(2K0?,;W+BXYAXB)N%ZT.Y[,]6?4J@5RO;>X>89J,I^?JM@DK
M5?EF;@ABNV\%9W<'6$J>#I(YT59-C#O9Q @^K%2L2]!-X3=,&[(Z>EKD5M?4
M*J*>00I:0D!!"3F# K(3XZ @E@T:IBO:9,73_I:.41/G A)21F+@A@ DO?1]
MP [:U9=SF3WMQEXG;WBID[EWSR2CX618U]$7*TC*JK$91E6BT&@&4.L8XI%=
M(D[2@;M;!WE(HDGANT?BNF$R7PYAA5)II*C(44J=DRB)2$D,/E"0'S;.UP1E
MN!\$J*F8K'*]!,Q:1-9:2^:8,ZE@GJ26R /H!O::Z/\ T\4V%@H6$91HSD,<
M[<[I![@=X$R@)7$1E3=J$.J?!^"VL@V[$IJH;:89X>[6V/,N[B5LC2S4CN.]
M83*)<9-.9,XS0LAP04ZA3N'U.CN'%B=3'5BR%*RG.%CNJ ;X?,!MCI8I8<[1
M</*''V'^/' C_$1Y'D?[-2P'EI$1]:F$&D(-(0:0@TA!I"#2$&D(^3 'N//@
M.>.0#V\_7@ Y^_(!_$-4*0Y<%CY$>'ASA"HNH'L^<WXD[G+&]*:7R=D*4XH&
M>\(K+-FK#<7ALQW"SJOHBY,V;M<F5+XAU-XTG#.6SM.9*6*%UZ#H"#-S9@H6
M"@22XW?30CK?DS1( 4I.91 !L7T]Z>#Q0'W>;1;MLAML1N3VZR4K=]J61IZ2
MBJ9;7#=<DI4)ILJL$W@O.,"LBV=T_(U9<HO&8LIM%O\ -_EAGT,X653>E:9?
M"L<K,"J9,^EFJERTS,RY=RE26(#AP]S8\_2,=BN%4V-R5T\^6E:B"$J 3F!3
MWG<NQ9.K6L&$95PWGZFY@CR%8N4HNRH(IFD*\[,*3TB@% %5XXINX)-B)QY3
M-'G=*E 0]4A [1-ZGX3XUH<?I$"=-DRI^4!:2R,V47;,<Q.G[CRZGSOQ)PK6
M8-43%2I<Y<A4Q@M*4J(=V'=2V4W=[V#<HFSA7<#FO;I-R$]A3(T_C]]+HIMY
M=K%J(.(B730$/A1E85XDYC'B[0H 1LLL@+M  !,YP[2$+?QK@K!L=/QE4CDG
M-\= S L%!G )(()46/+PCYL,XHQ#!D!":U2&9(EK!S:ZL&-B&?34V%X_#F'.
M68,^S:%ES-D.RY DV"1R1Y9AZ'RZ)1,;N5+%Q#<B4:R[NX1.9%L"A^?*G <:
MHPW@S!,+IY\F1+DJG3DY>^DI4"AV-V-W+Y6T(VA5\5XGB-1(FU"U"1*425IS
M6!(^5U$78.[W:]XLM;(LXU?*O3<QE4(U\G^:<%63'>*+E$' $GD<2NVADC57
MQ&YE?67CIFJEAUV[\ ]):12EV8?TT<N4/-'&F&3,+QRIEU",DF9-49)EBQL
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M71,*:A?/DR8  "(F[A#72Z#M-X>KTE5942Z:H 27F@I"E$D$)RA[,ZC8L1U
MT"N[/L<II:I-/*_42ENE&5B0   7#:CG=[C2V<Z?NGA:6I)O\8YY2I#J=8)1
MLPY@9MHC\T8(+E=-DG2$@@L@=9BZ(5U'O/ATWC!UWKLUTE%%1/9QBKX'XG$@
MSL2HTSI*Q,S)MF-M2M)LPZDGD3%["Z7B[AZG73R:&8I$P.$A*R0UM0H$'O6
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MQS>UW)!4$;)OKRA45B8MQHF<Q2R"VU'&UB:(KY+O#;DZ41D>UL"P$:Z(1S$
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M-IT+1(4H7!N+WTUT T;30.-K1">;Z&6(FRYN9/J:T_DY@^563IKVBXN$#%$
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MX$I1#@0 0XX$!#D!#["'U_T\Z@@'4>_9A'/:7GGM+SQQSP'/ >P<_8.1_MT
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8X]14K*.0;MP44X#O."?<;@.X1X#2$?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g202221g27l21.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g202221g27l21.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[28:4&AO=&]S:&]P(#,N,  X0DE-! 0
M    )?Z^ER8X0DE-! 0      %D< @   @  ' )0  AR<C,W-S Q,QP"!0!
M36EC<F]S;V9T(%=O<F0@+2!)<FED97@@+2!&;W)M(%,M,R M7T1204947R T
M.#0T+34X-#8M-3(V-"!V+C4N9  X0DE-!"4      !#TT;!  [>F&#//P5VK
M(7]U.$))300Z      #E    $     $       MP<FEN=$]U='!U=     4
M    4'-T4V)O;VP!     $EN=&5E;G5M     $EN=&4     0VQR;0    ]P
M<FEN=%-I>'1E96Y":71B;V]L      MP<FEN=&5R3F%M951%6%0    !
M   /<')I;G10<F]O9E-E='5P3V)J8P    P 4 !R &\ ;P!F "  4P!E '0
M=0!P       *<')O;V93971U<     $     0FQT;F5N=6T    ,8G5I;'1I
M;E!R;V]F    "7!R;V]F0TU92P X0DE-!#L      BT    0     0
M$G!R:6YT3W5T<'5T3W!T:6]N<P   !<     0W!T;F)O;VP      $-L8G)B
M;V]L      !29W--8F]O;       0W)N0V)O;VP      $-N=$-B;V]L
M  !,8FQS8F]O;       3F=T=F)O;VP      $5M;$1B;V]L      !);G1R
M8F]O;       0F-K9T]B:F,    !        4D="0P    ,     4F0@(&1O
M=6) ;^            !'<FX@9&]U8D!OX            $)L("!D;W5B0&_@
M            0G)D5%5N=$8C4FQT                0FQD(%5N=$8C4FQT
M                4G-L=%5N=$8C4'AL0%@            *=F5C=&]R1&%T
M86)O;VP!     %!G4'-E;G5M     %!G4',     4&=00P    !,969T56YT
M1B-2;'0               !4;W @56YT1B-2;'0               !38VP@
M56YT1B-0<F- 60           !!C<F]P5VAE;E!R:6YT:6YG8F]O;      .
M8W)O<%)E8W1";W1T;VUL;VYG          QC<F]P4F5C=$QE9G1L;VYG
M      UC<F]P4F5C=%)I9VAT;&]N9P         +8W)O<%)E8W14;W!L;VYG
M       X0DE- ^T      ! #O_XU  (  0.__C4  @ !.$))300F       .
M             #^    X0DE-! T       0   !:.$))3009       $
M'CA"24T#\P      "0           0 X0DE-)Q        H  0         !
M.$))30/U      !( "]F9@ ! &QF9@ &       ! "]F9@ ! *&9F@ &
M   ! #(    ! %H    &       ! #4    ! "T    &       !.$))30/X
M      !P  #_____________________________ ^@     ____________
M_________________P/H     /____________________________\#Z
M  #_____________________________ ^@  #A"24T$"       $     $
M  )    "0      X0DE-!!X       0     .$))300:      -!    !@
M            K@   +D    & %, 5 !? #  ,@ W     0
M           !              "Y    K@                     !
M                     !     !        ;G5L;     (    &8F]U;F1S
M3V)J8P    $       !28W0Q    !     !4;W @;&]N9P          3&5F
M=&QO;F<          $)T;VUL;VYG    K@    !29VAT;&]N9P   +D    &
M<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E    $@    =S;&EC
M94E$;&]N9P         '9W)O=7!)1&QO;F<         !F]R:6=I;F5N=6T
M   ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960     5'EP965N=6T
M   *15-L:6-E5'EP90    !);6<@    !F)O=6YD<T]B:F,    !
M4F-T,0    0     5&]P(&QO;F<          $QE9G1L;VYG          !"
M=&]M;&]N9P   *X     4F=H=&QO;F<   "Y     W5R;%1%6%0    !
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M3001       ! 0 X0DE-!!0       0    $.$))300,     !MX     0
M (L   "#   !I   UNP  !M< !@  ?_8_^T #$%D;V)E7T--  +_[@ .061O
M8F4 9(     !_]L A  ," @("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,
M# P,#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P, 0T+"PT.#1 .#A 4
M#@X.%!0.#@X.%!$,# P,#!$1# P,# P,$0P,# P,# P,# P,# P,# P,# P,
M# P,# P,# S_P  1" "# (L# 2(  A$! Q$!_]T !  )_\0!/P   04! 0$!
M 0$          P ! @0%!@<("0H+ 0 !!0$! 0$! 0         !  (#! 4&
M!P@)"@L0  $$ 0,"! (%!P8(!0,,,P$  A$#!"$2,05!46$3(G&!,@84D:&Q
M0B,D%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$
MP]-UX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G
M]Q$  @(! @0$ P0%!@<'!@4U 0 "$0,A,1($05%A<2(3!3*!D12AL4(CP5+1
M\#,D8N%R@I)#4Q5C<S3Q)086HK*#!R8UPM)$DU2C%V1%539T9>+RLX3#TW7C
M\T:4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H # ,!
M  (1 Q$ /P#U5))))2DDDDE*0,W.Q,#&?EYMS,?'J$OML<&M';Z3OWOS56ZO
MUBGIE5?Z-V3EY+O2P\.N/4NLC=L;N]M==;?TF1D6?H:*OTEB\LZ]]:\F_J'Z
M![.H]5K=MJR&#?BXKFG<ZOHV/8-E^2UW\[U?*;^9^K?HTE/9]4^O9JJ]7%95
MA8SP'59G5"^KU6D_3PNE4-?U/+8YOT7OKQ%R>=_C!-I+79O4<N7$QCBCIU4?
MFMK]F?U#;_7RUB4]&?;:[*ZE<^_(L,V'<7.<?^%R'[GV?V5L=+Z0_*RF873<
M=@N>"22-K6L; ?;=;#G[6[F_Z1^]3#EY5Q2/ /%B.>-U$<1:_P#SX?/MP<TC
MQ=U7.+OO8&,_Z"-C?7\56B7]5PYT.W+KS //T>K8Q>[^KZK/^,6_E?5.W%ZG
MTSIS\XO=U$WA]C*PT,]&OUF[&/?;NW_0?O?_ -MJAU[ZN9?22W[7Z>7B7.V,
MO#8&Z-WIW4O-GIN<UOL_26,_XM(8X2( GJ>X4<DP+,-/ NMT?Z_79)96VS'Z
MFYVT>@T?8<[6=VS$S++<'-?_ .%.H?\ 6UUG2^M=.ZHRPXEI-M) R,>QKJ[J
MG'\S(QK@RZG^TS^HO&\KH>'>T^D/1<?#W,GSK/T?[*EB]=ZGTNZBKJAMM91'
MV3/I,Y=#6D^W$R;/;EXON_3=*SO4HL_X)-R89PW&G<+H98SVW[/N"=8'U?\
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M QI_[9K6JJH
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 1$  A$! Q$!_\0 'P   @(" @,!              D("@<+ 08"! 4#_\0
M2Q    8" 0,"! 0!" 0*"P   0(#! 4&!P@1  D2$R$*%!4Q%B)!47$7&!DC
M)#(Y85*!H;$E)RDS-D)G>)&W1D=)5%57=Y*VP?#_Q  < 0$  04! 0
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MCITN=<2I@1%4H]9;6?#3A3!I5.9V(I)3+0DE:@Y(0!=W8D@N+:@Z%XQ \?\
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M6 <N P^I:^EC/%N6,>YOH-2RGB6Z0%_QU=8Q";J]NK#Y.2B)EBH=9-0J"Z(
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MPEK;$$L$[<FX%AJUR9\F3+EKDJ20J6D!+ E)2&8,7=V!!&46NIJ29 XX$ $
MXY 2@')@'RY$O   @/Y@#Q#@P\@ <=6=(+ER2Q(UL6W;371K/II%XMJ S_[_
M #"D6@?\N3/![<?T8T)[!]O;9:3X 0_RY]O;CVZORF'#X:S51(Z.5:<O;18;
MG'RY<?I68FP!2"S'8J&9A9[ZPU\_B)%"@4#JB8P)&4("R8&3$X$,9N*Z!E 2
M.<PG(D8BJR9 *!Q$Q.K",B)B99+K43-2"P(?O.DW8AV!%QJ=XOH':!R 4@E)
M+6[IRWL^H;TNQNKO7#M(ZEX4ISR)R)C6A[ 7JR.'SNUWK*='A+, ?4'R[AK
MTZ!L24S&TNOPS5<&*"$(@TDIL6Z,M./GTL*CD;O5\28O-F4]/*G34T]/E(_Y
M%#*E/RD]XC,$LX/@&-S:_P#"8<9DZ=,DI4J?F!=(WU2 0$MY$L  6#17S[IN
MF]&TXS]4F>*B/(O%.9JQ,VVNUAV^D98E,G:5,0L9=H"'?2R[N35KJJ5FJ$M%
M1K]RZ=1IY><8-5R0J-?9L][_  JXGJZZ542*A2JM"%$YE$S%)+GO=X=V[_)8
M$*;1AJ7C?A^BPI*U2R)$N>I2@$)2FZR202DL<I8NHE364Y_Y%++D(]G),5XZ
M29(O(]XDNS>,G!"+-UFRJ2C5XP<^0#RB?U5! H%%,QC',!3<B([9KJ)&)(G4
ME41-HYR"2A3**0JX"@HJ!4D$/F //2-74%0NAFF?1E0RE^W45!0Y9%6(&6X9
M5@01H\*_ML;D_1C/%$V"P199>HO:[9T;+0[1'G55>5J::F4.YKDB &*TF(9]
M&)NVBK%X DL$"O(04H5S'MY)LXY:XXX*G8/53ZBF29=(9\TR,G=!DF8KLR0D
M ?\ C .X+FPWZ)X*XJEXG32J6?,[2:B3*0M2R5%2LB0I;J)/>4[DZ."YUBZ_
MVM-[:0_?XUR92TFM3U=WLOTK4;AC5JL"L%IMW(0;J6"V4&#]0Q098:VV(=[?
M<>-RKN&K#))?I"18V1N[F"::_21E<]=2]PU[Z<_LQO&<3%)"\H8@%@1N-B6N
M2=-3SU=[/!!Y*4>0'DI1Y*/D4>0 >2F "@8/V$"AR'OP'VZD:#\:>41[]ZQY
M=(0=(0=(0=(0=(0=(0=(0=(0=(0O/N8; 6[ >KEC0Q0<%L^YUM5.UGUU8@H9
M)4^9LZS1J?7)=J=+@RAJ3'K3F0728 !2M*DX^<5(W-YA!EE:%)![R25N_>RY
MG9VT:P#[,VIBJ6/^0DN4I020UK ^1+ML_,W$:]_NTY&B[;L!B_M]X$D4IC"^
MDL4CKO477KNDF^0,XRCMF[V&RQ8/4557<3-PR@26:S$N!SH%CZ\67(L<7@J#
MZL-I)V)U]%32$NM<Q,E4L.$E 5E$PI 8YAJI27)N^K^&NJ9=!15F(S5_\:4'
M*"Q"&!^0$@9G/= OHQ=A$J-8-<I6RS=*P/CEH=)HSKTK8;9:UH6>M#NNU^)5
MB0GKFXI-"AY2[W-=62L#%RK!T^'>2#:+<R<ZY5:5V EGAND\2KZ3X>83229%
M,)TQ=+([0I0D-,$E"5 $ ?OL+LYN01&B,+H/^L\9JITZIFI0B=.*0J9,4"C.
MO*6)(T 8D'D;N8>1%]BRV7&CM[CBK=G#^22/V1W40I'X9E&%1F5B<I&;(7>"
MSA<2L$VCDATW;HE3EUV91!-S%)*E$A<(D_&>OS&F-!+[!7=S!(S$:.;?-S!5
MNZF)8994_#*0I(G2JG--21E2; W#.4A6P )RAW!<L8R%VF*=D[3+>'+NK^PM
M3-1;AG/$,;.T6037&5IF0W&#+#/NG!\=V5-$C.?;?AO*4O+NFK]&/M<(TAA_
M%];A%W,6F\QGC;':3'Y5)62TH-1+2)96$@3$ (8H"BD'(G1+$)"0"GNV5?.$
M<%J<'F54F:5=DH$JEE1R%1+@E(5E)+J?4DG1P2+.A2$!/W3(4!#GP\2^)?(
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MCZDY5J>3:^NM&R$VW1=$DXQ91JZ9V>EKMCMGK9T@9)9!X=LM"F;+IJ$<)JL
M%(Y10)XZ7^+F$FEQ6GK0D!<\#,4@.%J+J2&W#D/>X-HVG\-L3%1AAHIJCGE+
M![ZBH@!GNY8>>KOK%]OM/[ -KSG_ "'(,E425K>W537?N#P4<P_)&0^6F,>E
MKGMK%E9%\2)RQLBU2BR\DJ@']:M(KK+E,<X#UJ1(4E613N+*<N<R;'<%W'+1
MK,\;,6Q)*=,Q:X/=)<-=V9M=R?-_Q/[I0X /RE]@X$ ]@]@$  . _3@ #]@
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MY5IA-LZ1B99Q&1JB:S.5B)F.K<]$S,#!]/<&<44F.44V=)(34K&=0!':2US
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MB"=/_$K$,/J)4JG29:YR%%![H*P4J8@DI! \"0=BXBN7N8;C MC(H'"II6L
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M^CAG'H4I*& FH46 92L[%@2Q)<V86;5P"2QR:4"B0 -Y@<Y0$1#[^0AR(@(
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MU77Z9;RT(FI2K*E*% @*2Z0Q8*8'0M;DVM\U7.7,4I1) 62KLW(2D*+Y<MP
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M';ILW%-1D]W,SW7DF+NAU"57(+H^!\5G9LHMLL]CG,C6G3=15QXI8,CORP5
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M[B->GV @X[NVFX>P %ER-]@_[%\A\?;]P .?TYX_3J#SZI'U_LQ,;3D/L'\
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M'_6$ $>1 .C#E[.OK"%1=X[M]1O<1TTN^,XM@R-F2A^>2<#S#DXH'1OL$V<
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M]1(_7ME#O%F5=W6M(Y1=J% R=CR;75GMS2]$K9W'/6DU!2RII))H0WT3\J?
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M:BXF+[@P?*2M<("**)G4C)T!?YZ\5M!,7"YHT+Q!QR;F0G6#%-Z==GT'F?\
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M[,LFHK".M@7\2SDY9DR08NIIK'ED#(I(B=14$$R ;D=^6WJ>O0<MH7Y#U?\
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FA#I3BL"_?1:$FZ49DX,9$\,-0P/-KOOO[\[3X^=_ZBS[U,(__]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
